Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.

The US Food and Drug Administration (FDA) has approved a new treatment option for narcolepsy.

The US Food and Drug Administration (FDA) has issued a warning for certain products used to clean and disinfect CPAP devices.

You will soon see new cigarette packaging in stores near you.

The US Food and Drug Administration (FDA) has strengthened a drug safety warning for a schizophrenia medication.

Whether you have tried many times to quit smoking or you have never once tried to quit, a new year means another chance to successfully kick the habit.

The number of lung injuries related to electronic cigarette use continues to rise.

The US Food and Drug Administration (FDA) has approved a first-of-its-kind patch for schizophrenia.

Can a nutritional supplement help manage depression symptoms? New research suggests that it's possible.

Health officials have declared lack of sleep a public health problem.